Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Xeris Pharmaceuticals, Inc 8.3

9th Aug 2021 14:23

RNS Number : 0474I

J.P. Morgan Securities LLC

09 August 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	J.P. Morgan Securities LLC
Company dealt in	Xeris Pharmaceuticals, Inc.
Class of relevant security to which the dealings being disclosed relate (Note 2)	$0.001 common stock
Date of dealing	06 August 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,004,791 6.02		134,463 0.20
(2) Derivatives (other than options)	124,443 0.19
(3) Options and agreements to purchase/sell
Total	4,129,234 6.21		134,463 0.20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit (USD)

(Note 5)

Purchases

Sales

1,770,701

1,500

1,700

100

52,776

799

700

21,146

378

4,878

22,327

3,814

2,699

2,495

13,813

1,869

38,178

36,716

23,900

22,938

2,964

5,800

23,489

1,257

11,666

3,198

21,336

19,376

30,753

6,845

13,200

7,502

14,350

5,926

3,641

5,822

3,952

6,377

11,000

4,357

2,151

5,000

3,900

1,500

57,400

5,145

12,384

193

1,099

29,593

900

18,018

693

10,768

19,067

5,307

1,460

2,780

1,100

4,119

799

3,446

2.4000 USD

2.3100 USD

2.3125 USD

2.3150 USD

2.3156 USD

2.3187 USD

2.3200 USD

2.3204 USD

2.3250 USD

2.3300 USD

2.3306 USD

2.3332 USD

2.3339 USD

2.3350 USD

2.3358 USD

2.3400 USD

2.3401 USD

2.3429 USD

2.3442 USD

2.3450 USD

2.3500 USD

2.3502 USD

2.3509 USD

2.3513 USD

2.3541 USD

2.3542 USD

2.3550 USD

2.3572 USD

2.3573 USD

2.3600 USD

2.3609 USD

2.3622 USD

2.3627 USD

2.3634 USD

2.3650 USD

2.3690 USD

2.3700 USD

2.3748 USD

2.3750 USD

2.3763 USD

2.3800 USD

2.3850 USD

2.3867 USD

2.3903 USD

2.3950 USD

2.4000 USD

2.4035 USD

2.4050 USD

2.4100 USD

2.4135 USD

2.4144 USD

2.4183 USD

2.4200 USD

2.4207 USD

2.4263 USD

2.4312 USD

2.4438 USD

2.4500 USD

2.4550 USD

2.5200 USD

2.5250 USD

2.5300 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(USD) (Note 5)

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and

any other person relating to the voting rights of any relevant securities under any option referred to

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to

which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure	09 August 2021
Contact name	Alwyn Basch
Telephone number	0207 742 7407
If a connected EFM, name of offeree/offeror with which connected	N/A
If a connected EFM, state nature of connection (Note 10)	N/A

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEZZGGRFLGGMZM

Related Shares:

FTSE 100 Latest

Value8,621.83

Change79.27